Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.65M Hold
22,067
1.97% 16
2025
Q4
$2.32M Hold
22,067
1.66% 18
2025
Q3
$1.85M Hold
22,067
1.36% 22
2025
Q2
$1.75M Hold
22,067
1.33% 23
2025
Q1
$1.98M Hold
22,067
1.58% 21
2024
Q4
$2.2M Buy
+22,067
New +$2.27M 1.75% 18
2022
Q3
$1.94M Hold
22,182
2.4% 12
2022
Q2
$2.02M Hold
22,182
2.41% 13
2022
Q1
$1.82M Hold
22,182
1.95% 17
2021
Q4
$1.7M Buy
+22,182
New +$1.77M 1.85% 17

Other funds holding MRK

Enhancing Capital's MRK Position: Q1 2026 in Review

Enhancing Capital held its Merck (MRK) position steady in Q1 2026 at 22,067 shares worth $2.65M. The position accounts for 1.97% of the portfolio, ranked #16.

Enhancing Capital first reported a position in MRK in Q4 2021 and has held it in 10 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Enhancing Capital held 22,067 shares of Merck worth $2.65M as of Q1 2026.
  • Enhancing Capital left its Merck share count unchanged in Q1 2026.
  • Merck made up 1.97% of Enhancing Capital's portfolio in Q1 2026, its #16 holding.
  • Enhancing Capital first reported a position in Merck in Q4 2021 and has held it in 10 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Enhancing Capital's 13F filing for Q1 2026, filed 8 May 2026.